NASTAD Announces 2018-2019 Board of Directors

FOR IMMEDIATE RELEASE May 31, 2018

CONTACT: Kyle Taylor ktaylor@nastad.org | 202.434.7134

NASTAD Announces 2018-2019 Board of Directors

Washington, DC - Last week, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world, announced its 2018-2019 Board of Directors. NASTAD is governed by a 23-member, elected Board charged with making policy and program decisions on behalf of the full membership.   The 2018-2019 Board of Directors includes:   Officers (Executive Committee)

  • Jacquelyn Clymore, North Carolina, Chair
  • Johanne Morne, New York, Chair-Elect
  • Jeffrey Hitt, Maryland, Vice-Chair
  • Michael Kharfen, District of Columbia, Secretary-Treasurer 
  • DeAnn Gruber, Louisiana, Immediate Past-Chair (ex-officio)

  Board Members

  • Sharon Jordan, Alabama
  • Susan Jones, Alaska
  • John Sapero, Arizona
  • Karen Mark, California
  • Dave Kern, Chicago
  • William Lyons, Georgia
  • Peter Whiticar, Hawaii
  • Marlene McNeese, Houston
  • Aimee Shipman, Idaho
  • Eduardo Alvarado, Illinois
  • Randy Mayer, Iowa
  • Dawn Fukuda, Massachusetts
  • James Stewart, Mississippi
  • Andrew Gans, New Mexico
  • Demetre Daskalakis, New York City
  • Jan Fox, Oklahoma
  • Tracey Packer, San Francisco
  • Beth Crutsinger-Perry, Washington
  • Murray C. Penner, NASTAD Executive Director (ex-officio)

  “It is my pleasure to welcome the 2018-2019 Board of Directors,” said Murray Penner, NASTAD Executive Director. “I look forward to a productive and eventful year as we work together under the guidance of our Board Chair’s Challenge: Achieving Health Equity to End the Epidemics. By strengthening partnerships, promoting leadership, and eliminating stigma and discrimination, we can end the HIV and hepatitis epidemics.”

About NASTAD

Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.